Ischemic stroke patients not receiving life-saving treatment, study finds
Ischemic stroke patients who do not receive intravelous (IV) alteplase, a clot-dissolving medication, are significantly less likely to survive, according to researchers at Georgia State University. Ischemic stroke is the most common type of stroke. It occurs when a...
Geography matters: Inequalities in Access to Stroke Care and Innovation
A debate on stroke is emerging in Brussels for the first time, thanks to the joint mobilisation of physicians’ association ESO and the patients’ association Stroke Alliance for Europe – SAFE over the past year. This mobilisation started off with a joint letter sent on...
Migraine with aura may raise stroke risk
By Honor Whiteman Published on www.medicalnewstoday.com The risk of stroke could be increased by more than a quarter for people who experience migraine with aura. So concludes a twin study recently published in the journal Brain. According to the Migraine Research...
The Action Plan on Stroke in Europe: Link for online registration is now OPEN
Jon Barrick, SAFE President, invites stroke advocates from European stroke support organisations to step forward and register for the Munich consensus conference - March 2018 The“Action Plan for Stroke in Europe 2018 to 2030” will be of major importance for the...
SAFE starts building the Stroke Support Organisation Faculty Tool
This September, SAFE started developing a standalone tool Learning Management System (LMS) that can be accessed by SAFE members online in any location. This project's title is Stroke Support Organisation Faculty Tool (SSOFT) The SAFE board approved the appointment of...
SAFE Annual Report 2018
Stroke Action Plan for Europe 2018-2030
Life with spasticity
The Burden of Stroke in Europe Report
